HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transplacental measles immunity in infants in the 1st year of life].

Abstract
A total of 187 parturients (66 with a history of measles and 121 immunized with live measles vaccine, or LMV, in childhood) and their 187 newborn infants, as well as 195 children aged up to 1 year, were examined. Antimeasles antibodies in blood sera were detected in the hemagglutination inhibition test. In all mothers with a history of measles and in their newborn infants antimeasles antibodies in different titers were detected. In mothers, formerly immunized with LMV, antimeasles antibodies were absent in 5.8% and in their newborn infants, in 6.6% of the examinees. Among children aged up to 1 year, born of formerly immunized mothers, more rapid disappearance of passive antimeasles immunity was observed. In cases of contact with measles, the serological examinations of all children born of mothers immunized with LMV should be carried out in order to protect seronegative children by passive or active immunization.
AuthorsL V Bystriakova, R V Zaĭtseva, L V Kolobova, E A Pushkareva, I P Smorodinova
JournalZhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) Issue 10 Pg. 50-2 (Oct 1991) ISSN: 0372-9311 [Print] Russia (Federation)
Vernacular TitleSostoianie korevogo transplatsentarnogo immuniteta u deteĭ pervogo goda zhizni.
PMID1839342 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antibodies, Viral
  • Measles Vaccine
Topics
  • Adolescent
  • Adult
  • Antibodies, Viral (blood)
  • Female
  • Hemagglutination Inhibition Tests
  • Humans
  • Infant
  • Infant, Newborn
  • Maternal-Fetal Exchange (immunology)
  • Measles (immunology, prevention & control)
  • Measles Vaccine (immunology)
  • Measles virus (immunology)
  • Pregnancy
  • Russia
  • Urban Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: